TrialBeacon
OTHERClinicalTrials.govClinical trialCompleted

Timing of Rectal Cancer Resection After Preoperative Chemoradiotherapy

Open the official recordBack

Official record

Identifier
NCT02441153
Recruiting locations
Locations are not included in the offline baseline for this record. Open the official record to see the current site list.
Interventions studied
Extended Timing
Lead sponsor
Health Sciences North Research Institute
Target enrolment
50 participants
Study type
OBSERVATIONAL
Phase
Not provided in the official record
Status
Completed
First posted
May 12, 2015
Last updated on the registry
Oct 1, 2026
Age
18 Years
Sex
ALL
Study contact
No public contact is listed on the official record.
Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Adult patients (\>18 years)
* T3/4N0M0 or TxN+M0 rectal cancer below or at the peritoneal reflection, confirmed on clinical exam, histology, pelvic MRI, and CT chest/abdo
* Patients who have completed a CRT protocol for the above tumor at HSN
* Informed consent given
* Surgical resection with TME planned

Exclusion Criteria:

* Metastatic disease
* Failure to complete preoperative CRT
* Unable to give free and informed consent
* Unable to comply with the requirements of the study
* Previous malignancy other than nonmelanoma skin cancer, papillary or follicular thyroid cancer
* Inflammatory bowel disease
* Hereditary colorectal cancer
Indexed under
Colorectal Cancer